CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors
Meiyang Xi(Shaoxing University), Haopeng Sun(China Pharmaceutical University), Dichapong Kanjanawasee(Shaoxing University), Lemao Yu(Shaoxing University), Tingkai Chen(China Pharmaceutical University), Chunlei Wu(Shaoxing University), Xiang Luo(Shaoxing University), Kui Du(Shaoxing University), Yonghua Wu(Shaoxing University), Xiaozhong Gao(Shaoxing University), Runpu Shen(Shaoxing University)
Cited by 67
Related Papers
Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
|European Journal of Medicinal Chemistry|2018|200
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196